These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 17508409)

  • 1. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
    Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
    Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of skp2 expression in primary breast cancer.
    Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
    Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
    Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Wu KL; Zhao S
    Lung Cancer; 2007 Apr; 56(1):105-14. PubMed ID: 17166620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.
    Brabender J; Danenberg KD; Metzger R; Schneider PM; Lord RV; Groshen S; Tsao-Wei DD; Park J; Salonga D; Hölscher AH; Danenberg PV
    Clin Cancer Res; 2002 Feb; 8(2):438-43. PubMed ID: 11839661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I
    Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome.
    Yang J; Xu Z; Li J; Zhang R; Zhang G; Ji H; Song B; Chen Z
    J Urol; 2010 Jul; 184(1):336-43. PubMed ID: 20488473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].
    Qian XP; Liu BR; Shi MQ; Liu XZ; Hu WJ; Zou ZY; Wei J
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):33-7. PubMed ID: 19538866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Int6 expression can predict survival in early-stage non-small cell lung cancer patients.
    Buttitta F; Martella C; Barassi F; Felicioni L; Salvatore S; Rosini S; D'Antuono T; Chella A; Mucilli F; Sacco R; Mezzetti A; Cuccurullo F; Callahan R; Marchetti A
    Clin Cancer Res; 2005 May; 11(9):3198-204. PubMed ID: 15867213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
    Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
    Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.